DEVELOPMENT OF THE EXTEMPORAL OINTMENT COMPOSITION FOR THE PSORIASIS TREATMENT
DOI:
https://doi.org/10.30888/2415-7538.2017-06-05-035Keywords:
psoriasis, ointments, extemporaneousAbstract
We consider the creation extemporal ointment for the psoriasis treatmentMetrics
References
Love T. J, Qureshi A. A., Karlson E. W. et al. Prevalence of the metabolic syndrome in psoriasis: results from the national health and nutrition examination survey, 2003—2006 // Arch Dermatol. 2011, Apr; 147 (4): 419— 424
Mrowietz U, Kragballe K, Nast A., Reich K. Strategies for improving the quality of care in psoriasis with the use of treatment goals-a report on an implementation meeting // J Eur Acad Dermatol Venereol. 2011, May; 25, Suppl 3: 1—13
А.К. Тимонин. Ботаника. Высшие растения (Том 3) Издательство: Академия Год: 2007- С.256; Кочетков Н.К. // Химия природных соединений. – 2008. – С.225
Reich K., Langley R. G., Lebwohl M. et al. Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies//Br J Dermatol. 2011, Apr; 164 (4): 862—872
